Green James W's Form 4 filing
Harvard Bioscience Inc (HBIO) · filed Dec 2, 2022
- Accession no.
- 0000921895-22-003154
- Filed
- Dec 2, 2022
- Trade date
- Nov 30-Dec 1, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $75.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Green James WCIK 0001400121 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2022 | Common Stock | PPurchaseAcquired | +15,000 | $2.41 | +$36,150 | 2,263,811 | Direct | |
| Dec 1, 2022 | Common Stock | PPurchaseAcquired | +15,000 | $2.61 | +$39,150 | 2,278,811 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.